Düsseldorf, 9 March 2021 – NOVACOS has advised investment firm Triton Fund V alongside De Brauw Blackstone Westbroek on an agreement to invest in Bergman Clinics, one of the leading chains of independent clinics in the Netherlands, Germany and Scandinavia. This investment will be in partnership with the current shareholders consisting of the Malenstein family and NPM Capital. The agreement is subject to the completion of the consultation process with Bergman Clinics’ works council and customary regulatory approvals.
Bergman Clinics is a leading specialist for treatments in the field of orthopedics, ophthalmology, gynecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine. Bergman Clinics grew its network of clinics through an active acquisition strategy and currently owns 140 focus clinics. More than 3,000 employees and more than 250 specialists work at Bergman Clinics.
The investment by Triton will help Bergman Clinics to further expand its geographical footprint, and creates room to invest in technological innovation, digitization and training. Both clients and employees can benefit directly from this. “Bergman Clinics is strongly positioned in the field of outpatient care which is an increasingly important part of the healthcare services sector. The company has a strong medical platform and digital backbone to further expand as a focused specialty care player in Europe,” emphasized Anja Bickelmaier, Co-Head of Healthcare at Triton.
The Triton funds invest in and support the positive development of medium-sized businesses primarily in German-speaking countries, the Nordic countries, the Benelux region, France, Italy, Spain and the United Kingdom. The 46 companies currently in Triton’s portfolio have combined sales of around 18.2 billion euros and around 100,800 employees.
The transaction was led by the Dutch law firm De Brauw Blackstone Westbroek. The NOVACOS team (led by Maria Heil) advised on the German regulatory and healthcare-specific aspects (including hospital and medical care centers law) which play a decisive role in investments in health care facilities. ARQIS (led by Dr. Jörn-Christian Schulze) advised on the German transactional aspects. NOVACOS and ARQIS act regularly for the Triton funds.
Team NOVACOS: Maria Heil (Lead, Partner, M&A/Life Sciences), Dr. Marc Oeben (Partner, M&A/Life Sciences), Dr. Friederike Juncker (Life Sciences).
Here you will find our Press Release – Bergman